Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1996-11-21
1998-11-24
Leary, Louise N.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 4, 530300, 530323, 530324, 530325, 530326, 530327, 530328, 530329, 530330, 530350, 530382, 514 2, 514 21, C12Q 102, C12Q 100
Patent
active
058405143
ABSTRACT:
The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents.
REFERENCES:
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4018653 (1977-04-01), Mennen et al.
patent: 4424279 (1984-01-01), Bohn et al.
patent: 5051448 (1991-09-01), Shashoua
patent: 5169862 (1992-12-01), Burke, Jr. et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5264358 (1993-11-01), Doersen et al.
patent: 5436221 (1995-07-01), Kitaguchi et al.
patent: 5492890 (1996-02-01), Ginsburg et al.
patent: 5523209 (1996-06-01), Ginsberg et al.
patent: 5539085 (1996-07-01), Bischoff et al.
patent: 5548062 (1996-08-01), Isoai et al.
patent: 5559103 (1996-09-01), Gaeta et al.
patent: 5576423 (1996-11-01), Aversa et al.
P. Calabresi and B.A. Chabner, "Antineoplastic Agents," In: Goodman and Gilman The Pharmacological Basis of Therapeutics (Pergamon Press, 8th Edition) (pp. 1209-1216) (1985).
J.H. Gerlach et al., "Multidrug Resistance," Cancer Surveys, 5:25-46 (1986).
J.H. Goldie and Andrew J. Coldman, "The Genetic Origin of Drug Resistance in Neoplasms: Implications for Sstemic Therapy," Cancer Research, 44:3643-3653 (1984).
D. Livant et al., "Invasion of Selectivity Permeable Sea Urchin Embryo Basement Membranes by Metastatic Tumor Cells, But Not By Their Normal Counterparts," Cancer Research 55:5085 (1995).
Bresalier et al., "The Laminin 1 Chain Ile-Lys-Val-Ala-Val (IKVAV)-Containing Peptide Promotes Liver Colonization by Human Colon Cancer Cells," Cancer Research 55:2476 (1995).
Eldred et al., "Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) pheny1!-1-piperaziny1!-1-piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent," J. Med. Chem., 37:3882 (1994).
Ku et al., "Potent Non-Peptide Fibrinogen Receptor Antagonists Which Present An Alternative Pharmacophore," J. Med. Chem., 38:9 (1995).
W.R. Pearson and D.J. Lipman, "Improved Tools For Biological Sequence Comparison," Proc. Natl. Acad. Sci. (USA), 85:2444-2448 (1988).
D.J. Lipman and W.R. Pearson, "Rapid and Sensitive Protein Similarity Searches," Science, 227:1435-1441 (1985).
Douillard and Hoffman, "Basic Facts about Lymphocytes Hybridomas," Compendium of Immunology vol. II, ed. by Schwartz (1981).
G. Kohler and C. Milstein, "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity," Nature, 256:495-497 (1975).
G. Kohler and C. Milstein, "Derivation of Specific Antibody-Producing Tissue Culture and Tumor Lines By Cell Fusion," European Journal of Immunology, 6:511-519 (1976).
C.L. Reading, "Theory and Methods For Immunization in Culture and Monoclonal Antibody Production," Journal of Immunological Methods, 53:261-291 (1982).
T.K. Gartner et al., "The Tetrapeptide Analogue of the Cell Attachement Site of Fibronectin Inhibitis Platelet Aggregation and Fibrinogen Binding to Activated Platelets," The Journal of Biological Chemistry, 260:11891-11894 (1985).
N.S. Nicholson et al., "In Vitro and In Vivo Effects of a Peptide Mimetic (SC-47643) of RGD As An Antiplatelet and Antithrombotic Agent," Thrombosis Research, 62:567-578 (1995).
M. Nomizu et al., "Multimeric Forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) Peptide Enhance the Inhibition of Tumor Growth and Metastasis," Cancer Research, 53:3459-3461 (1993).
I. Saiki et al., "Inhibition of the Metastasis of Murine Malignant Melanoma By Synthetic Polymeric Peptides Containing Core Sequences of Cell-Adhesive Molecules," Cancer Research, 49:3815-3822 (1989).
R.H. Wenger et al., "Cloning of cDNA Coding For Connective Tissue Activating Peptide III From a Human Platelet-Derived AgtII Expression Library," Blood,73(6):1498-1503 (1992).
Aota et al; J. Biological Chem, vol. 269(4), (Oct. 7, 1994), pp. 24756-24761.
Leary Louise N.
The Regents of the University of Michigan
LandOfFree
Methods of testing cancer and anticancer drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of testing cancer and anticancer drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of testing cancer and anticancer drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1700645